[10-K/A] Oramed Pharmaceuticals Inc. Amends Annual Report

Filing Impact

(Low)

Filing Sentiment

(Neutral)

Form Type

10-K/A

Rhea-AI Filing Summary

Analyzing...

07/16/2025 - 04:05 PM

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Oramed Pharmaceuticals Inc

#6687 Ranked by Market Cap

N/A Ranked by Dividends

Apr 28, 2025

Mar 4, 2025

Feb 11, 2025

Oct 7, 2024

Jun 26, 2024

Jul 16, 2025

Market Cap 86.60M

Float 34.49M

Insiders Ownership 13.64%

Institutions Ownership 19.13%

Short Percent 1.53%

Industry Biotechnology

Sector Pharmaceutical Preparations

Website Link

Country United States

City NEW YORK